Several other analysts have also recently weighed in on the stock. Deutsche Bank set a €110.00 ($135.80) price objective on shares of Hannover Rueck and gave the stock a neutral rating in a research note on Friday, February 2nd. Barclays set a €105.40 ($130.12) price objective on shares of Hannover Rueck and gave the stock a sell rating in a research note on Thursday, February 1st. JPMorgan Chase & Co. set a €108.00 ($133.33) price objective on shares of Hannover Rueck and gave the stock a neutral rating in a research note on Friday, January 26th. Credit Suisse Group set a €120.00 ($148.15) price objective on shares of Hannover Rueck and gave the stock a buy rating in a research note on Thursday, January 25th. Finally, Commerzbank reissued a neutral rating on shares of Hannover Rueck in a research note on Monday, January 22nd. Three equities research analysts have rated the stock with a sell rating, seventeen have given a hold rating and four have issued a buy rating to the stock. Hannover Rueck currently has an average rating of Hold and an average price target of €109.33 ($134.97).
Shares of Hannover Rueck (HNR1) opened at €111.20 ($137.28) on Wednesday. Hannover Rueck has a one year low of €94.75 ($116.98) and a one year high of €116.37 ($143.67). The firm has a market cap of $13,310.00 and a price-to-earnings ratio of 14.42.
Hannover Rueck Company Profile
Hannover R??ck SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, and facultative, as well as credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Receive News & Ratings for Hannover Rueck Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Rueck and related companies with MarketBeat.com's FREE daily email newsletter.